close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.43 +0.01 (+0.04%)
Official Closing Price Updated: 7:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Why Shares of Eli Lilly Soared This Week
Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs. 
Via The Motley Fool
Topics Government World Trade
Eli Lilly And Its Competitors Pop On The Pfizer News
Eli Lilly and other US-based drug makers have led the market over the last few days. 
Via Talk Markets
US Government Plunges into Shutdown: Markets Brace for Impact as Stalemate Continues
As of October 3, 2025, the United States federal government finds itself in the throes of a significant shutdown, marking the eleventh such occurrence in modern American history and the third under... 
Via MarketMinute
Topics Economy Government
These 3 Stocks Pay More Than 6%. Are Their Dividend Yields Too Good to Be True?
Dividend stocks can be great income-producing investments, but chasing high yields can sometimes leave you exposed to considerable risk. 
Via The Motley Fool
How Trump’s 100% Tariff Threat Forced Pfizer’s Hand — Inside The High-Stakes Talks That Changed Big Pharma’s Course
Via Stocktwits
Topics Government
A Look Into Pfizer Inc's Price Over Earnings
 
Via Benzinga
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October
You don't need to be rich to put your money to work on Wall Street. 
Via The Motley Fool
Topics Intellectual Property
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy?
The pharma giant just eliminated two big risks. 
Via The Motley Fool
Topics Government Intellectual Property World Trade
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Pfizer Stock Hits 9-Month High As Analysts Dismiss Trump Drug Deal’s Financial Risk; Retail Stays ‘Extremely Bullish’
Via Stocktwits
Topics Government
Federal Shutdown Paralysis: Data Delays Deepen Economic Damage Fears
The United States economy finds itself navigating treacherous waters as a federal government shutdown grips the nation, sparking heightened concerns about widespread economic damage. What makes this... 
Via MarketMinute
Topics Economy Initial Public Offering Regulatory Compliance
Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength
Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC.... 
Via MarketMinute
Topics Economy
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics Government World Trade
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics World Trade
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount. 
Via Benzinga
FTSE 100 Stumbles: Commodity Crossroads for UK's Resource-Exposed Giants
London's benchmark FTSE 100 index experienced a slight retreat on October 2, 2025, closing down 0.23% at the end of a trading day that saw it touch new record highs before succumbing to a complex mix... 
Via MarketMinute
Topics Climate Change Derivatives Economy
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active S&P500 stocks in today's session. 
Via Chartmill
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
The uncertainty about U.S. pharmaceutical tariffs shouldn't be as worrisome for AstraZeneca now. 
Via The Motley Fool
Topics Government World Trade
Why Charles River Laboratories (CRL) Stock Is Up Today
Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target. 
Via StockStory
Topics Government
Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design
London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented... 
Via TokenRing AI
Topics Artificial Intelligence
AI Revolutionizes Pharma: Market Soars Towards $65 Billion by 2033, Promising a New Era of Medicine
The pharmaceutical industry is on the cusp of a profound transformation, driven by the accelerating integration of Artificial Intelligence (AI). Projections indicate that the global AI in... 
Via TokenRing AI
Topics Artificial Intelligence Economy
3 Things You Need to Know if You Buy Pfizer Today
Pfizer has an attractive 7.2% dividend yield, but there are some pros and cons you need to understand before you buy it. 
Via The Motley Fool
Topics Intellectual Property
3 Mega Dividend Stocks With Yields as High as 13.4%
These dividend stocks offer the potential to produce big-time income streams. 
Via The Motley Fool
Why AbbVie Stock Cruised to an Almost 6% Gain Today
A new expansion project and a win for a peer pharmaceutical company were attracting investors to the shares. 
Via The Motley Fool
Topics Government World Trade
Why BioNTech Stock Jumped by Nearly 4% on Wednesday
The company's push deeper into a hot new technology, plus good news from a top collaborator, put the shine on its equity. 
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
US Government Shutdown Rocks Global Markets: A Deep Dive into the Economic Aftershocks
Washington D.C., October 1, 2025 – The United States federal government has officially entered a shutdown today, marking the first such funding lapse in nearly seven years and sending immediate ripples... 
Via MarketMinute
Topics Economy Government Regulatory Compliance
FTSE 100 Soars to Record High, Fueled by Pharmaceutical Boom and Resilient Pound
London, UK – October 1, 2025 – The UK's benchmark FTSE 100 index has achieved an unprecedented milestone today, surging to a new all-time high. The robust performance was largely propelled by a... 
Via MarketMinute
Topics Brexit Government World Trade
Top 3 Dividend Achievers for October: High Yields, Growth Ahead
High-yield Dividend Achievers, such as United Parcel Service, Verizon, and Pfizer, offer attractive entry points in October for income investors. 
Via MarketBeat
Topics Artificial Intelligence World Trade
Healthcare Heavyweights Drive London's Blue-Chip Index to Unprecedented Levels
London's financial markets are buzzing today, October 1, 2025, as a robust rally in the pharmaceuticals sector has propelled the FTSE 100 to a new record high. This significant surge, primarily fueled... 
Via MarketMinute
Topics Economy Government World Trade
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today